350 related articles for article (PubMed ID: 25186232)
21. A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity.
D'Angelo F; Vignaud H; Di Martino J; Salin B; Devin A; Cullin C; Marchal C
Dis Model Mech; 2013 Jan; 6(1):206-16. PubMed ID: 22888099
[TBL] [Abstract][Full Text] [Related]
22. PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression.
Kumon H; Yoshino Y; Funahashi Y; Mori H; Ueno M; Ozaki Y; Yamazaki K; Ochi S; Mori T; Iga JI; Nagai M; Nomoto M; Ueno SI
J Alzheimers Dis; 2021; 79(3):1055-1062. PubMed ID: 33386803
[TBL] [Abstract][Full Text] [Related]
23. Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production.
Guimas Almeida C; Sadat Mirfakhar F; Perdigão C; Burrinha T
Cell Mol Life Sci; 2018 Jul; 75(14):2577-2589. PubMed ID: 29704008
[TBL] [Abstract][Full Text] [Related]
24. Relationship between genetic risk factors and markers for Alzheimer's disease pathology.
Elias-Sonnenschein LS; Bertram L; Visser PJ
Biomark Med; 2012 Aug; 6(4):477-95. PubMed ID: 22917148
[TBL] [Abstract][Full Text] [Related]
25. Partial loss of CALM function reduces Aβ42 production and amyloid deposition in vivo.
Kanatsu K; Hori Y; Takatori S; Watanabe T; Iwatsubo T; Tomita T
Hum Mol Genet; 2016 Sep; 25(18):3988-3997. PubMed ID: 27466196
[TBL] [Abstract][Full Text] [Related]
26. LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.
Sen A; Arslan M; Erdal ME; Ay OI; Yilmaz SG; Kurt E; Arpaci B
Ideggyogy Sz; 2015 Mar; 68(3-4):113-20. PubMed ID: 26434199
[TBL] [Abstract][Full Text] [Related]
27. Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
Thomas RS; Alsaqati M; Bice JS; Hvoslef-Eide M; Good MA; Kidd EJ
Neuroreport; 2017 Oct; 28(15):963-968. PubMed ID: 28885485
[TBL] [Abstract][Full Text] [Related]
28. Implication of common and disease specific variants in CLU, CR1, and PICALM.
Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
[TBL] [Abstract][Full Text] [Related]
29. APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.
Carter CJ
Neurosci Lett; 2010 Oct; 483(2):96-100. PubMed ID: 20674675
[TBL] [Abstract][Full Text] [Related]
30. Association of MTHFR and PICALM polymorphisms with Alzheimer's disease.
Belcavello L; Camporez D; Almeida LD; Morelato RL; Batitucci MC; de Paula F
Mol Biol Rep; 2015 Mar; 42(3):611-6. PubMed ID: 25359311
[TBL] [Abstract][Full Text] [Related]
31. Association of Alzheimer's disease risk variants on the
Xu W; Tan CC; Cao XP; Tan L;
Aging (Albany NY); 2020 Nov; 12(21):21202-21219. PubMed ID: 33170153
[TBL] [Abstract][Full Text] [Related]
32. An intronic PICALM polymorphism, rs588076, is associated with allelic expression of a PICALM isoform.
Parikh I; Medway C; Younkin S; Fardo DW; Estus S
Mol Neurodegener; 2014 Aug; 9():32. PubMed ID: 25169757
[TBL] [Abstract][Full Text] [Related]
33. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
Zhu D; Su Y; Fu B; Xu H
Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
[TBL] [Abstract][Full Text] [Related]
34. Genetic Association between Alzheimer's Disease Risk Variant of the PICALM Gene and Auditory Event-Related Potentials in Aging.
Ponomareva NV; Andreeva TV; Protasova MA; Filippova YV; Kolesnikova EP; Fokin VF; Illarioshkin SN; Rogaev EI
Biochemistry (Mosc); 2018 Sep; 83(9):1075-1082. PubMed ID: 30472946
[TBL] [Abstract][Full Text] [Related]
35. Epistatic genetic effects among Alzheimer's candidate genes.
Hohman TJ; Koran ME; Thornton-Wells T;
PLoS One; 2013; 8(11):e80839. PubMed ID: 24260488
[TBL] [Abstract][Full Text] [Related]
36. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.
Jones L; Harold D; Williams J
Biochim Biophys Acta; 2010 Aug; 1801(8):754-61. PubMed ID: 20420935
[TBL] [Abstract][Full Text] [Related]
37. Quantitative EEG during normal aging: association with the Alzheimer's disease genetic risk variant in PICALM gene.
Ponomareva NV; Andreeva TV; Protasova MS; Shagam LI; Malina DD; Goltsov AY; Fokin VF; Illarioshkin SN; Rogaev EI
Neurobiol Aging; 2017 Mar; 51():177.e1-177.e8. PubMed ID: 28073596
[TBL] [Abstract][Full Text] [Related]
38. The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum.
Xu W; Wang HF; Tan L; Tan MS; Tan CC; Zhu XC; Miao D; Yu WJ; Jiang T; Tan L; Yu JT;
Sci Rep; 2016 Apr; 6():24480. PubMed ID: 27117083
[TBL] [Abstract][Full Text] [Related]
39. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
[TBL] [Abstract][Full Text] [Related]
40. Identification and confirmation of an exonic splicing enhancer variation in exon 5 of the Alzheimer disease associated PICALM gene.
Schnetz-Boutaud NC; Hoffman J; Coe JE; Murdock DG; Pericak-Vance MA; Haines JL
Ann Hum Genet; 2012 Nov; 76(6):448-53. PubMed ID: 22943764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
